Cynthia Seidel-Dugan - Jan 3, 2023 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Chief Scientific Officer
Signature
/s/ Jonathan Owen, Attorney-in-fact
Stock symbol
HOWL
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 08:36 PM
Previous filing
Jan 14, 2022
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +116K $0.00 116K Jan 3, 2023 Common Stock 116K $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.

Remarks:

Exhibit Index: 24.1 Power of Attorney